Sign In
Buy INSM
$103.86
+0.130 (+0.125%)
At Close: Jun 03, 2026
The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection
12:00am, Thursday, 19'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week highs on March 18)
Biomerica, Inc. (NASDAQ...
ProShare Advisors LLC Has $749,000 Position in Insmed Incorporated (NASDAQ:INSM)
10:56am, Wednesday, 18'th Mar 2020
ProShare Advisors LLC cut its holdings in shares of Insmed Incorporated (NASDAQ:INSM) by 8.5% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commis
Insmed (INSM) Gets a Buy Rating from Credit Suisse
04:11pm, Tuesday, 17'th Mar 2020
In a report released yesterday, Martin Auster from Credit Suisse maintained a Buy rating on Insmed (INSM), with a price target of $42.00. The company's
Insmed (INSM) Gets a Buy Rating from Credit Suisse
04:11pm, Tuesday, 17'th Mar 2020
In a report released yesterday,
Martin Auster
from Credit Suisse maintained a
Buy
rating on Insmed (
INSM
–
Research Report
), with a price target of
$42.00
. The company’s shares closed last Mond
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs March 16.) * BioNTech SE - ADR (NASDAQ: BNTX) (announced eff
Bank of Montreal Can Has $673,000 Stock Holdings in Insmed Incorporated (NASDAQ:INSM)
08:40am, Tuesday, 17'th Mar 2020
Bank of Montreal Can grew its position in Insmed Incorporated (NASDAQ:INSM) by 25.3% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 28,1
Cowen & Co. Keeps Their Buy Rating on Insmed (INSM)
03:52am, Tuesday, 17'th Mar 2020
In a report released yesterday, Ritu Baral from Cowen & Co. maintained a Buy rating on Insmed (INSM), with a price target of $56.00. The company's
Cowen & Co. Keeps Their Buy Rating on Insmed (INSM)
03:52am, Tuesday, 17'th Mar 2020
In a report released yesterday, Ritu Baral from Cowen & Co. maintained a Buy rating on Insmed (INSM – Research
BRIEF-Insmed Says It Suspends Revenue Guidance
11:36pm, Monday, 16'th Mar 2020
Insmed Inc:
Insmed suspends revenue guidance amid coronavirus outbreak uncertainty
08:42pm, Monday, 16'th Mar 2020
Citing the impact of COVID-19, Insmed (NASDAQ:INSM) has suspended its 2020 revenue guidance of $180M - 220M.On the positive side, it has filed a marketing application in Japan for Arikayce (amikacin l
Insmed Provides Business Update
08:01pm, Monday, 16'th Mar 2020
Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today provided a general business update.
Franklin Resources Inc. Has $16.76 Million Holdings in Insmed Incorporated (NASDAQ:INSM)
11:29am, Monday, 16'th Mar 2020
Franklin Resources Inc. grew its holdings in shares of Insmed Incorporated (NASDAQ:INSM) by 6.0% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional inve
Insmed (NASDAQ:INSM) Stock Price Down 9.8%
08:02am, Friday, 13'th Mar 2020
Shares of Insmed Incorporated (NASDAQ:INSM) dropped 9.8% on Wednesday . The company traded as low as $21.05 and last traded at $21.25, approximately 1,269,628 shares changed hands during trading. A de
Insmed Incorporated to Post Q2 2020 Earnings of ($0.44) Per Share, SVB Leerink Forecasts (NASDAQ:INSM)
05:46am, Friday, 13'th Mar 2020
Insmed Incorporated (NASDAQ:INSM) – Analysts at SVB Leerink lifted their Q2 2020 earnings estimates for Insmed in a research report issued to clients and investors on Monday, March 9th. SVB Leerink
BidaskClub Downgrades Insmed (NASDAQ:INSM) to Sell
08:58am, Monday, 09'th Mar 2020
Insmed (NASDAQ:INSM) was downgraded by equities research analysts at BidaskClub from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Saturday, BidAsk
